Loading stock data...
Axsome Therapeutics, Inc. (AXSM) Stock Price, Chart & Analysis
Axsome Therapeutics, Inc.AXSM
Market Closed$116.99
+$5.70+5.12%
AXSM Market Indicators
Very Bullish
Market Sentiment
Historical Price Chart
View the historical price chart for AXSM to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Axsome Therapeutics, Inc. (AXSM)
Loading chart data...
Is Axsome Therapeutics, Inc. (AXSM) Stock a Buy in 2025?
YES
STRONG BUY
Score: 100/100
Yes, AXSM stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether AXSM stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 42.5%
- Healthcare sector momentum
- Mid-cap growth potential
Valuation Considerations
- Analyst price targets suggest 51.2% upside potential
Risk Factors
- High debt-to-equity ratio of 297.38
- Healthcare sector cyclicality
- Recent price volatility suggests market uncertainty
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$176.95
Upside Potential:51.2%
Investment Summary
AXSM presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 42.5%, though analyst price targets suggest 51.2% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 297.38, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:100/100
Strong Buy
2030 Price Prediction
Predicted Price:$357.03
Potential Return:+205.2%
Key Factors
- Exceptional revenue growth
- Very strong analyst buy consensus
- Very significant upside potential
- Exceptional long-term growth potential to 2030
- Moderate analyst consensus
- Debt-to-Market-Cap Ratio: 3.7% (Very Low)
Investment Decision
Based on our comprehensive analysis of AXSM's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
axsm Stock Price Prediction 2030
Predicted 2030 Price
$357.03
+205.2%from current price
Based on revenue growth analysis and market trends, axsm stock is projected to reach $357.03 by 2030, representing a 205.2% increase from the current price of $116.99.
Current Price
$116.99
Revenue Growth
72.1%
Analyst Target
$176.95
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in axsm Stock?
Quick Investment Insights for axsm
Low Volatility (Beta: 0.51)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Axsome Therapeutics, Inc.
Healthcare
Biotechnology
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercia...
Employees
846
Market Cap
$5.84B